Search Result "AKT-2"
Role of PI3K/AKT, cPLA2 and ERK1/2 Signaling Pathways in Insulin Regulation of Vascular Smooth Muscle Cells Proliferation
Journal: Cardiovascular & Hematological Disorders-Drug Targets
Volume: 9 Issue: 3 Year: 2009 Page: 172-180
Author(s): Esma R. Isenovic, Mamdouh H. Kedees, Snezana Tepavcevic, Tijana Milosavljevic, Goran Koricanac, Andreja Trpkovic, Pierre Marche
AKT and cytosolic phospholipase A2α form a positive loop in prostate cancer cells
Journal: Current Cancer Drug Targets
Volume: 15 Issue: 9 Year: 2015 Page: 781-791
Author(s): Sheng Hua,Soma Vignarajan,Mu Yao,Chanlu Xie,Paul Sved,Qihan Dong
Receptor Type Protein Tyrosine Phosphatase Epsilon (PTPRE) Plays anOncogenic Role in Thyroid Carcinoma by Activating the AKT andERK1/2 Signaling Pathway
Journal: Current Cancer Drug Targets
Volume: 23 Issue: 6 Year: 2023 Page: 471-481
Author(s):
Therapeutic Path to Triple Knockout: Investigating the Pan-inhibitoryMechanisms of AKT, CDK9, and TNKS2 by a Novel 2-phenylquinazolinoneDerivative in Cancer Therapy- An In-silico Investigation Therapy
Journal: Current Pharmaceutical Biotechnology
Volume: 25 Issue: 10 Year: 2024 Page: 1288-1303
Author(s): Xylia Q. Peters,Mohamed Issa Alahmdi,Nader E. Abo-Dya,Peter A. Sidhom,Ahmed M. Tawfeek,Mahmoud A. A. Ibrahim,Mahmoud E. S. Soliman
Recent Developments in Anti-Cancer Agents Targeting PI3K, Akt and mTORC1/2
Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 6 Issue: 2 Year: 2011 Page: 210-236
Author(s): Rodrigo Dienstmann, Jordi Rodon, Ben Markman, Josep Tabernero
Recent Developments in Anticancer Agents Targeting PI3K, AKT and mTORC1/2
Ebook: Topics in Anti-Cancer Research
Volume: 2 Year: 2013
Author(s): Irene Brana,Sara De Dosso,Rodrigo Dienstmann,Jordi Rodon,Josep Tabernero,Ben Markman
Doi: 10.2174/9781608051366113020007
SSPH I, A Novel Anti-cancer Saponin, Inhibits EMT and Invasion andMigration of NSCLC by Suppressing MAPK/ERK1/2 and PI3K/AKT/mTOR Signaling Pathways
Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 19 Issue: 4 Year: 2024 Page: 543-555
Author(s):
Canopy Fibroblast Growth Factor Signaling Regulator 2 (CNPY2) Inhibits Neuron Apoptosis in Parkinsonâs Disease via the AKT/GSK3β Pathway
Journal: Current Neurovascular Research
Volume: 18 Issue: 1 Year: 2021 Page: 102-112
Author(s): Miao Chu,Huimiao Liu,Zhaohui Xiong,Chaojuan Ju,Lina Zhao,Kangning Li,Shiqi Tian,Ping Gu
Synthesis and Bioevaluation of Quaternary Centered 3-hydroxy-3 (alkynyl)indolin-2-one Derivatives as Potential Cytotoxic Agents and Akt Kinase Inhibitors
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 17 Issue: 14 Year: 2017 Page: 1963-1970
Author(s): P. Sai Prathima,R. Bikshapathi,Y. Poornachandra,V. Himabindu,G. Jagadeesh Kumar,N. Jagadeesh,C. Ganesh Kumar,V. Jayathirtha Rao
Dauricine Inhibits Non-small Cell Lung Cancer Development byRegulating PTEN/AKT/mTOR and Ras/MEK1/2/ERK1/2 Pathways in aFLT4-dependent Manner
Journal: Current Cancer Drug Targets
Volume: 24 Issue: 11 Year: 2024 Page: 1157-1168
Author(s):